glp 1 drugs and gastroparesis GLP-1 Gastroparesis: Hidden Dangers Beyond C Study finds GLP-1 receptor agonists

"My hope is that we'll figure out ways that a young person won't have to be on a medication for the rest of their lives," Klein says

Recent insights into body composition changes, potential psychiatric effects, and perioperative risks highlight the importance of individualized care and ongoing monitoring

Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial

Glucagon receptor activation: Increases hepatic glucose output (relevant in fasted states), stimulates lipolysis in adipose tissue, and raises basal metabolic rate through thermogenic mechanisms

Aroda VR, Rosenstock J, Terauchi Y, et al

J Eur Acad Dermatology Venereology: JEADV